CN Patent

CN106986869A — 用于抗病毒治疗的化合物和方法

Assigned to Gilead Sciences Inc · Expires 2017-07-28 · 9y expired

What this patent protects

提供了用于治疗病毒感染的化合物及其药学上可接受的盐和酯类。所述化合物和组合物用于治疗肺炎病毒亚科病毒感染。所提供的化合物、组合物和方法特别地可用于治疗人呼吸道合胞病毒感染。

USPTO Abstract

提供了用于治疗病毒感染的化合物及其药学上可接受的盐和酯类。所述化合物和组合物用于治疗肺炎病毒亚科病毒感染。所提供的化合物、组合物和方法特别地可用于治疗人呼吸道合胞病毒感染。

Drugs covered by this patent

Patent Metadata

Patent number
CN106986869A
Jurisdiction
CN
Classification
—
Expires
2017-07-28
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.